Bavarian Nordic issues Financial Calendar for 2015
23 sept. 2014 02h00 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark, September 23, 2014 -...
Bavarian Nordic offentliggør finanskalender for 2015
23 sept. 2014 02h00 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark - 23. september 2014 -...
Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of IMVAMUNE(r) Smallpox Vaccine
04 sept. 2014 12h18 HE
|
Bavarian Nordic A/S
KVISTGAARD, Denmark, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Biomedical Advanced Research and Development Authority (BARDA), a division...
Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of IMVAMUNE® Smallpox Vaccine
04 sept. 2014 12h12 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Option valued at USD 118 million will fund...
Bavarian Nordic offentliggør udnyttelse af option i kontrakt med den amerikanske regering om fortsatte leverancer af IMVAMUNE® koppevaccine
04 sept. 2014 12h12 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Option på USD 118 mio. bidrager til...
Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health
04 sept. 2014 00h00 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark, September 4, 2014 -...
Bavarian Nordic fremskynder udviklingen af en ny ebolavaccine i samarbejde med U.S. National Institutes of Health
04 sept. 2014 00h00 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark - 4. september 2014 -...
Bavarian Nordic offentliggør regnskab for første halvår 2014
28 août 2014 01h44 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark, 28. august 2014 - Bavarian...
Bavarian Nordic Announces First Half 2014 Results
28 août 2014 01h44 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark, August 28, 2014 - Bavarian...
Bavarian Nordic Receives Order from the Canadian Government to Supply IMVAMUNE® Smallpox Vaccine
26 août 2014 01h30 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Ongoing contracts including options total more...